In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report) today and set a price target of $10.00. The company’s shares closed last Friday at $8.73.

The Ultimate Fighting Championship brought back the trend of featuring the fighters in customized shorts. The post Best to ...

PARADIP: Jagatsinghpur MP Bibhu Prasad Tarai on Thursday said JSW will set up its Rs 65,000 crore steel plant in Dhinkia in ...

Manisha Rani, the Bigg Boss OTT 2 sensation, is chanelling her Bihari traditions by celebrating the auspicious festival of Chhath Puja. As the people of Bihar and Uttar Pradesh indulge themselves in ...

This year, Sasthi Tithi commences on November 7. It is on this significant day that devotees perform Sandhya Arghya rituals, ...

Lifestyle can shape the composition of beneficial bacteria and other microorganisms within the mouth, according to a new ...

French dispute resolution boutique Clay Arbitration, along with U.S.-headquartered law firms White & Case and Willkie Farr & ...

Tesco has joined forces with its milk suppliers Arla and Müller UK & Ireland for a partnership that seeks to put ...

As per sources, the app will operate on a zero-commission model, guaranteeing direct payment to drivers. Customers, in turn, ...

Dr. Atul Prasad, Principal Director & HOD, Neurology, BLK - MAX Super Speciality Hospital, told IANS that longer life ...

Former selector MSK Prasad expresses concern over Virat Kohli's Test form as India prepares for the Border-Gavaskar Trophy against Australia. Kohli has struggled in the longest format of the game ...